Judith M. Matthews, Chief Financial Officer at Iterum Therapeutics plc (ITRM), bought 6,466 shares at $13.00 ($52K) on 2018-05-30, disclosed to the SEC on 2018-05-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,466 | $0 | 0.0% |
| 2 | $13.00 | 4,000 | $52K | 100.0% |
| Total | $8.04 avg | 6,466 | $52K | 100% |
| Filing → |
| ITRM | SELL | 2021-01-27 | $117K | — | Filing → |
| ITRM | SELL | 2020-10-02 | $184K | — | Filing → |